Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials
Christopher E.M. Griffiths, Kristian Reich, Mark Lebwohl, Peter Van De Kerkhof, Carle Paul, Alan Menter, Gregory S. Cameron, Janelle Erickson, Lu Zhang, Roberta J. Secrest, Susan Ball, Daniel K. Braun, Olawale O. Osuntokun, Michael P. Heffernan, Brian J. Nickoloff, Kim Papp
Research output: Contribution to journal › Article › peer-review
777Scopus
citations
Fingerprint
Dive into the research topics of 'Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials'. Together they form a unique fingerprint.